Tamara Lotan

Associate Professor (Fac)

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Prostatic Neoplasms Medicine & Life Sciences
Prostate Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences
Prostatic Intraepithelial Neoplasia Medicine & Life Sciences
Neoplasm Grading Medicine & Life Sciences
Immunohistochemistry Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2018

A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer

Graham, L., Banda, K., Torres, A., Carver, B. S., Chen, Y., Pisano, K., Shelkey, G., Curley, T., Scher, H. I., Lotan, T., Hsieh, A. C. & Rathkopf, D. E., Mar 6 2018, (Accepted/In press) In : Investigational New Drugs. p. 1-10 10 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Androgen Receptors
Cell Count

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer

Kaur, H. B., Guedes, L. B., Lu, J., Maldonado, L., Reitz, L., Barber, J. R., Demarzo, A. M., Tosoian, J. J., Tomlins, S. A., Schaeffer, E. M., Joshu, C. E., Sfanos, K. & Lotan, T., May 30 2018, (Accepted/In press) In : Modern Pathology. p. 1-14 14 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Cell Count
African Americans

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations

Antonarakis, E., Shaukat, F., Isaacsson Velho, P., Kaur, H., Shenderov, E., Pardoll, A. M. & Lotan, T., Jan 1 2018, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Prostatic Neoplasms
Disease-Free Survival

Clinical implications of PTEN loss in prostate cancer

Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., Demarzo, A. M., Squire, J. A. & Lotan, T., Apr 1 2018, In : Nature Reviews Urology. 15, 4, p. 222-234 13 p.

Research output: Contribution to journalReview article

Phosphoric Monoester Hydrolases
Prostatic Neoplasms
Phosphatidylinositol 3-Kinases

Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer

Haffner, M. C., Guner, G., Taheri, D., Netto, G. J., Palsgrove, D. N., Zheng, Q., Guedes, L. B., Kim, K., Tsai, H., Esopi, D. M., Lotan, T., Sharma, R., Meeker, A. K., Chinnaiyan, A. M., Nelson, W. G., Yegnasubramanian, S., Luo, J., Mehra, R., Antonarakis, E., Drake, C. G. & 1 othersDemarzo, A. M., Jun 1 2018, In : American Journal of Pathology. 188, 6, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Programmed Cell Death 1 Receptor
Small Cell Carcinoma